EVEROLIMUS 0.25 MG TABLET

Everolimus
$2.1478per EA

Strength

.25 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377006911

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216140

On Market Since

6/2/2025

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price History

1W

0.0%

1M

-6.2%

3M

-7.9%

6M

-4.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-4.2%